|
Most patients with congestive heart failure (CHF) will need to learn to live with the condition. Approximately two thirds of people with CHF die within five years of their diagnosis. However, some patients live long lives with CHF by making lifestyle changes and taking medication. Patient guidelines for living with CHF:
The American Heart Association recommends that patients with CHF limit their intake of sodium to 2,400 milligrams (mg) or less per day or to the amount their physicians recommend. This is approximately equal to one teaspoon of sodium per day. Cholesterol intake should also be limited to approximately 300 mg, with a total fat intake of approximately 65 mg and saturated fat intake of 20 grams. Because the physical effects of stress can be strenuous on a weakened heart, patients with CHF should be careful to avoid stressful situations. Of course, completing avoid stress is impossible and having a diagnosis of CHF tends to increase anxiety in most people. Physicians should advise patients to minimize stress by exercising regularly, taking time to relax every day, getting plenty of rest, planning activities in advance, trying to maintain a positive disposition, joining a support group or talking regularly with friends or family members, or seeking professional counseling if necessary. In many cases, moderate exercise such as walking, light jogging, or bicycling can benefit patients with CHF by increasing energy levels and working to lower cholesterol or blood pressure levels and obesity. Stress tests on patients should be performed to help devise an appropriate exercise regimen for each patient with CHF. Sometimes, supervised physical activity at cardiac centers or hospitals may be a favorable option. Patients with CHF should be monitored by physicians on a regular basis. Patients with CHF and/or those taking care of them should also report any new symptoms immediately. These symptoms include severe dyspnea, increased swelling in the ankles, legs or abdomen, increased fatigue, a new cough, and weight gain. Currently, only 20% of patients with CHF live longer than eight to 12 years with the condition, and the risk of sudden death from CHF is significant. In the United States, deaths from CHF tend to be higher in African Americans than Caucasians. However researchers are engaged in research to better understand the causes of CHF and improve prevention, diagnosis, treatment and survival. Current research includes inserting grafted cells into the heart to replace damaged ones, developing multi-action drugs to treat CHF, improving heart transplants (including xenotransplantation, the use of animal hearts), and improving left ventricular assist devices (LVAD). Updated: August 2006 |
||
Imaginis.com suscribes to the HONcode principles of the Health on the Net Foundation.
Copyright 1997-2009 Imaginis Corporation. All rights reserved. Imaginis® is a registered service mark of Imaginis Corporation, a health services company. All other trademarks and copyrights are property of their respective owners. Note: Use of this online service is subject to the disclaimer and the terms and conditions contained herein. Information found within the Imaginis.com website or in other sites linked to from Imaginis.com is provided for educational purposes only and is not intended to be used as a substitute for diagnosis and treatment by a medical doctor. Imaginis does not endorse and has no responsibility for the content of any other sites listed on Imaginis.com, and provides links and references merely as a convenience to its users. Seek immediate medical attention if your condition is urgent. Imaginis - The Breast Cancer Resource